Drug Safety Consulting Business Raising Funds In Bengaluru
Email
Phone
Google
LinkedIn
Facebook
About Business
Services Offered: Regulatory affairs
Active Study Contracts: 2
Therapeutic Areas: General
The proposed business will provide scientific consulting services to pharmaceutical and biotechnology companies, helping them assess drug safety and make informed decisions during early-stage drug development. It will focus on toxicology, risk assessment, computational modeling, and regulatory planning.
Core Services
The planned offering will combine early-stage drug safety assessments, predictive toxicology, toxicokinetic analysis, pharmacometrics, drug exposure modeling, alternative testing strategies, and regulatory guidance for preclinical development.
Business Model
The business will follow an asset-light, B2B model, delivering scientific assessments and recommendations while partnering with qualified external laboratories for testing requirements. This approach will limit the need for investment in laboratory infrastructure.
The founder has 12 years of experience in the sector.
Clientele type
The business will initially target small biotech companies that lack in-house drug safety experts. Other potential customers include research service providers, pharmaceutical and generic drug companies, medical device developers, and businesses in the chemical and agricultural sectors.
Premises
The business will operate from leased premises.
What’s on offer
The transaction terms will be negotiated with the prospective investor.
Reason
Invest in technology / R&D
Keywords
Business Tags
Fundraising for ₹10 Cr – 500 Cr
Confidential Process Completed in 120 Days
Strategic Preparation, Aligned Investor Outreach and Seamless Closure
Supported by Advisors with 26+ Years of Experience
